Use of Flavored E-Cigarettes Among Adolescents, Young Adults, and Older Adults: Findings From the Population Assessment for Tobacco and Health Study

The use of flavored electronic cigarettes (e-cigarettes) is common among e-cigarette users, but little is known about the potential harms of flavorings, the extent to which the concurrent use of multiple flavor types occurs, and the correlates of flavor type use. The objective of this study was to a...

Full description

Saved in:
Bibliographic Details
Published in:Public health reports (1974) Vol. 134; no. 3; p. 282
Main Authors: Soneji, Samir S, Knutzen, Kristin E, Villanti, Andrea C
Format: Journal Article
Language:English
Published: United States 01.05.2019
Subjects:
ISSN:1468-2877, 1468-2877
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The use of flavored electronic cigarettes (e-cigarettes) is common among e-cigarette users, but little is known about the potential harms of flavorings, the extent to which the concurrent use of multiple flavor types occurs, and the correlates of flavor type use. The objective of this study was to assess the types of e-cigarette flavors used by adolescent (aged 12-17), young adult (aged 18-24), and older adult (aged ≥25) e-cigarette users. We assessed the prevalence of flavored e-cigarette use within the past month by flavor types and concurrent use of multiple flavor types among past-month e-cigarette users sampled during Wave 2 (2014-2015) of the Population Assessment for Tobacco and Health Study among 414 adolescents, 961 young adults, and 1711 older adults. We used weighted logistic regression models for the use of fruit-, candy-, mint/menthol-, tobacco-, or other-flavored e-cigarettes and concurrent use of multiple flavor types. Covariates included demographic characteristics, e-cigarette use frequency, cigarette smoking status, current use of other tobacco products, and reasons for e-cigarette use. The leading e-cigarette flavor types among adolescents were fruit, candy, and other flavors; among young adults were fruit, candy, and mint/menthol; and among older adults were tobacco or other flavors, fruit, and mint/menthol. Compared with older adults, adolescents and young adults were more likely to use fruit-flavored e-cigarettes (adjusted odds ratio [aOR] = 3.35; 95% confidence interval [CI], 2.56-4.38; and aOR = 2.31; 95% CI, 1.77-3.01, respectively) and candy-flavored e-cigarettes (aOR = 3.81; 95% CI, 2.74-5.28; and aOR = 2.95; 95% CI, 2.29-3.80, respectively) and concurrently use multiple flavor types (aOR = 4.58; 95% CI, 3.39-6.17; and aOR = 2.28; 95% CI, 1.78-2.91, respectively). Regulation of sweet e-cigarette flavors (eg, fruit and candy) may help reduce the use of e-cigarettes among young persons without substantially burdening adult e-cigarette users.
AbstractList The use of flavored electronic cigarettes (e-cigarettes) is common among e-cigarette users, but little is known about the potential harms of flavorings, the extent to which the concurrent use of multiple flavor types occurs, and the correlates of flavor type use. The objective of this study was to assess the types of e-cigarette flavors used by adolescent (aged 12-17), young adult (aged 18-24), and older adult (aged ≥25) e-cigarette users.OBJECTIVESThe use of flavored electronic cigarettes (e-cigarettes) is common among e-cigarette users, but little is known about the potential harms of flavorings, the extent to which the concurrent use of multiple flavor types occurs, and the correlates of flavor type use. The objective of this study was to assess the types of e-cigarette flavors used by adolescent (aged 12-17), young adult (aged 18-24), and older adult (aged ≥25) e-cigarette users.We assessed the prevalence of flavored e-cigarette use within the past month by flavor types and concurrent use of multiple flavor types among past-month e-cigarette users sampled during Wave 2 (2014-2015) of the Population Assessment for Tobacco and Health Study among 414 adolescents, 961 young adults, and 1711 older adults. We used weighted logistic regression models for the use of fruit-, candy-, mint/menthol-, tobacco-, or other-flavored e-cigarettes and concurrent use of multiple flavor types. Covariates included demographic characteristics, e-cigarette use frequency, cigarette smoking status, current use of other tobacco products, and reasons for e-cigarette use.METHODSWe assessed the prevalence of flavored e-cigarette use within the past month by flavor types and concurrent use of multiple flavor types among past-month e-cigarette users sampled during Wave 2 (2014-2015) of the Population Assessment for Tobacco and Health Study among 414 adolescents, 961 young adults, and 1711 older adults. We used weighted logistic regression models for the use of fruit-, candy-, mint/menthol-, tobacco-, or other-flavored e-cigarettes and concurrent use of multiple flavor types. Covariates included demographic characteristics, e-cigarette use frequency, cigarette smoking status, current use of other tobacco products, and reasons for e-cigarette use.The leading e-cigarette flavor types among adolescents were fruit, candy, and other flavors; among young adults were fruit, candy, and mint/menthol; and among older adults were tobacco or other flavors, fruit, and mint/menthol. Compared with older adults, adolescents and young adults were more likely to use fruit-flavored e-cigarettes (adjusted odds ratio [aOR] = 3.35; 95% confidence interval [CI], 2.56-4.38; and aOR = 2.31; 95% CI, 1.77-3.01, respectively) and candy-flavored e-cigarettes (aOR = 3.81; 95% CI, 2.74-5.28; and aOR = 2.95; 95% CI, 2.29-3.80, respectively) and concurrently use multiple flavor types (aOR = 4.58; 95% CI, 3.39-6.17; and aOR = 2.28; 95% CI, 1.78-2.91, respectively).RESULTSThe leading e-cigarette flavor types among adolescents were fruit, candy, and other flavors; among young adults were fruit, candy, and mint/menthol; and among older adults were tobacco or other flavors, fruit, and mint/menthol. Compared with older adults, adolescents and young adults were more likely to use fruit-flavored e-cigarettes (adjusted odds ratio [aOR] = 3.35; 95% confidence interval [CI], 2.56-4.38; and aOR = 2.31; 95% CI, 1.77-3.01, respectively) and candy-flavored e-cigarettes (aOR = 3.81; 95% CI, 2.74-5.28; and aOR = 2.95; 95% CI, 2.29-3.80, respectively) and concurrently use multiple flavor types (aOR = 4.58; 95% CI, 3.39-6.17; and aOR = 2.28; 95% CI, 1.78-2.91, respectively).Regulation of sweet e-cigarette flavors (eg, fruit and candy) may help reduce the use of e-cigarettes among young persons without substantially burdening adult e-cigarette users.CONCLUSIONSRegulation of sweet e-cigarette flavors (eg, fruit and candy) may help reduce the use of e-cigarettes among young persons without substantially burdening adult e-cigarette users.
The use of flavored electronic cigarettes (e-cigarettes) is common among e-cigarette users, but little is known about the potential harms of flavorings, the extent to which the concurrent use of multiple flavor types occurs, and the correlates of flavor type use. The objective of this study was to assess the types of e-cigarette flavors used by adolescent (aged 12-17), young adult (aged 18-24), and older adult (aged ≥25) e-cigarette users. We assessed the prevalence of flavored e-cigarette use within the past month by flavor types and concurrent use of multiple flavor types among past-month e-cigarette users sampled during Wave 2 (2014-2015) of the Population Assessment for Tobacco and Health Study among 414 adolescents, 961 young adults, and 1711 older adults. We used weighted logistic regression models for the use of fruit-, candy-, mint/menthol-, tobacco-, or other-flavored e-cigarettes and concurrent use of multiple flavor types. Covariates included demographic characteristics, e-cigarette use frequency, cigarette smoking status, current use of other tobacco products, and reasons for e-cigarette use. The leading e-cigarette flavor types among adolescents were fruit, candy, and other flavors; among young adults were fruit, candy, and mint/menthol; and among older adults were tobacco or other flavors, fruit, and mint/menthol. Compared with older adults, adolescents and young adults were more likely to use fruit-flavored e-cigarettes (adjusted odds ratio [aOR] = 3.35; 95% confidence interval [CI], 2.56-4.38; and aOR = 2.31; 95% CI, 1.77-3.01, respectively) and candy-flavored e-cigarettes (aOR = 3.81; 95% CI, 2.74-5.28; and aOR = 2.95; 95% CI, 2.29-3.80, respectively) and concurrently use multiple flavor types (aOR = 4.58; 95% CI, 3.39-6.17; and aOR = 2.28; 95% CI, 1.78-2.91, respectively). Regulation of sweet e-cigarette flavors (eg, fruit and candy) may help reduce the use of e-cigarettes among young persons without substantially burdening adult e-cigarette users.
Author Knutzen, Kristin E
Soneji, Samir S
Villanti, Andrea C
Author_xml – sequence: 1
  givenname: Samir S
  surname: Soneji
  fullname: Soneji, Samir S
  organization: 2 Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Geisel School of Medicine, Lebanon, NH, USA
– sequence: 2
  givenname: Kristin E
  surname: Knutzen
  fullname: Knutzen, Kristin E
  organization: 2 Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Geisel School of Medicine, Lebanon, NH, USA
– sequence: 3
  givenname: Andrea C
  surname: Villanti
  fullname: Villanti, Andrea C
  organization: 3 Vermont Center on Behavior and Health, Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, VT, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30857471$$D View this record in MEDLINE/PubMed
BookMark eNpNkE1LAzEQhoNU_L57khw9uJpks5vEWynWCoUK6sFTyWYn7Uo2qZus4P_wB7vWCs5lZh5eHpg5RiMfPCB0Tsk1pULcEJLnecEVVTInqhR76IjyUmZMCjH6Nx-i4xjfyFCM5gfoMCeyEFzQI_T1EgEHi6dOf4QOanyXTZqV7iAliHjcBr_C4zo4iAZ8ilf4NfRb1LufTfsaL1wN3Y7c4mnj68avIp52ocVpDfgxbHqnUxM8HscIMbaDCdvQ4edQaWPC1jID7dIaP6W-_jxF-1a7CGe7foJepnfPk1k2X9w_TMbzzHDJU6ZIxYuigDInhCtiLTWsssYIUpKaQ1UIBVJZyZlVugAwphJmQCWVkGsL7ARd_no3XXjvIaZl2wx3Oqc9hD4uGVWES8YZG6IXu2hftVAvN13T6u5z-fdJ9g3PYniZ
CitedBy_id crossref_primary_10_1177_26320770241254719
crossref_primary_10_1080_09603123_2024_2431241
crossref_primary_10_1186_s12954_021_00484_6
crossref_primary_10_1136_tobaccocontrol_2021_056599
crossref_primary_10_1016_j_addbeh_2024_108176
crossref_primary_10_1016_j_ypmed_2021_106582
crossref_primary_10_1016_j_drugalcdep_2020_108258
crossref_primary_10_3390_ijerph22071073
crossref_primary_10_2196_42241
crossref_primary_10_11144_Javeriana_rgps22_ccen
crossref_primary_10_1016_j_abrep_2020_100273
crossref_primary_10_1213_ANE_0000000000005519
crossref_primary_10_18332_tid_162365
crossref_primary_10_1093_ntr_ntae194
crossref_primary_10_1136_tc_2022_057492
crossref_primary_10_1038_d41586_019_02920_x
crossref_primary_10_1136_bmjopen_2022_070212
crossref_primary_10_1007_s12170_019_0634_9
crossref_primary_10_1016_j_jhealeco_2025_103013
crossref_primary_10_1001_jamanetworkopen_2019_19393
crossref_primary_10_1136_tc_2023_058312
crossref_primary_10_1007_s00467_021_05001_2
crossref_primary_10_1136_tc_2022_057781
crossref_primary_10_3390_ijerph18010240
crossref_primary_10_1097_01_NURSE_0000694780_89896_37
crossref_primary_10_1136_tobaccocontrol_2019_055551
crossref_primary_10_18332_tid_191994
crossref_primary_10_1038_s41533_022_00277_9
crossref_primary_10_18332_tid_172078
crossref_primary_10_1016_j_neuropharm_2020_108162
crossref_primary_10_1136_tobaccocontrol_2021_057180
crossref_primary_10_1080_10826084_2022_2034876
crossref_primary_10_1093_ntr_ntaa095
crossref_primary_10_1038_s41598_025_97491_5
crossref_primary_10_1093_ntr_ntac272
crossref_primary_10_1093_ntr_ntac276
crossref_primary_10_3390_ijerph21040464
crossref_primary_10_1016_j_drugalcdep_2022_109475
crossref_primary_10_1080_10826084_2021_1942052
crossref_primary_10_3390_toxics10080471
crossref_primary_10_3390_ijms21103495
crossref_primary_10_1111_add_16082
crossref_primary_10_1080_10410236_2025_2449726
crossref_primary_10_1016_j_ypmed_2020_106145
crossref_primary_10_1093_ntr_ntz222
crossref_primary_10_1097_01_NURSE_0000694912_88938_09
crossref_primary_10_1016_j_ypmed_2024_107870
crossref_primary_10_1111_dar_13435
crossref_primary_10_18332_tid_174710
crossref_primary_10_1093_ntr_ntaa238
crossref_primary_10_1016_j_addbeh_2019_106054
crossref_primary_10_1080_10826084_2025_2522162
crossref_primary_10_1136_thorax_2023_221169
crossref_primary_10_1093_jnci_djaa118
crossref_primary_10_1136_tc_2022_057454
crossref_primary_10_1136_tobaccocontrol_2020_055999
crossref_primary_10_1097_YCO_0000000000000617
crossref_primary_10_1016_j_addbeh_2022_107290
crossref_primary_10_1136_tobaccocontrol_2020_056321
crossref_primary_10_1093_ntr_ntaa248
crossref_primary_10_1016_j_addbeh_2020_106519
crossref_primary_10_1016_j_fct_2020_111245
crossref_primary_10_1136_tobaccocontrol_2021_057073
crossref_primary_10_1016_j_drugalcdep_2023_109834
crossref_primary_10_18332_tid_130961
crossref_primary_10_1093_ntr_ntaf092
crossref_primary_10_3390_ijerph19127219
crossref_primary_10_3390_medicina58030412
crossref_primary_10_1016_j_addbeh_2020_106773
crossref_primary_10_1016_j_drugalcdep_2022_109685
crossref_primary_10_1093_ntr_ntad212
crossref_primary_10_1111_1468_0009_70051
crossref_primary_10_1513_AnnalsATS_201906_472OC
crossref_primary_10_1016_j_drugalcdep_2020_107903
crossref_primary_10_1016_j_jhealeco_2022_102676
crossref_primary_10_3390_cells12212552
crossref_primary_10_1177_07340168211001914
crossref_primary_10_1007_s10900_020_00948_z
crossref_primary_10_1093_ntr_ntac073
crossref_primary_10_1177_1179173X20959700
crossref_primary_10_3390_ijerph20043383
crossref_primary_10_1016_j_jadohealth_2019_05_004
crossref_primary_10_1038_s42003_024_07272_5
crossref_primary_10_1016_j_addbeh_2022_107436
crossref_primary_10_1016_j_pedn_2022_01_006
crossref_primary_10_1136_tc_2022_057359
crossref_primary_10_3390_healthcare11030382
crossref_primary_10_3390_ijerph16162991
crossref_primary_10_1080_10826084_2019_1710209
crossref_primary_10_1093_ije_dyab017
crossref_primary_10_1186_s12982_025_00842_w
crossref_primary_10_1016_j_neuropharm_2021_108672
crossref_primary_10_3390_ijerph18010207
crossref_primary_10_1093_ntr_ntab033
crossref_primary_10_1177_1524839919879928
crossref_primary_10_1136_bmjopen_2024_097974
crossref_primary_10_3390_ijerph16245055
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1177/0033354919830967
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Public Health
EISSN 1468-2877
ExternalDocumentID 30857471
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: P20 GM103644
GroupedDBID ---
--K
-TM
-~X
..I
.55
0R~
0ZK
123
1B1
1KJ
29P
2KS
2WC
3O-
53G
54M
5RE
5VS
76W
7K8
85S
8R4
8R5
96U
AABMB
AACMV
AADUE
AAEWN
AAFWJ
AAGLT
AAIKC
AAJPV
AAMNW
AANEX
AAPII
AAQFI
AAQXI
AARDL
AARIX
AATAA
AAWTL
ABAWP
ABAWQ
ABBHK
ABCCA
ABCJG
ABEIX
ABFNE
ABFWQ
ABIDT
ABJNI
ABKRH
ABLUO
ABPNF
ABPPZ
ABQDR
ABQIJ
ABQXT
ABRHV
ABUJY
ABWJO
ABXSQ
ACARO
ACBMB
ACDIW
ACDSZ
ACDXX
ACFEJ
ACGFO
ACGFS
ACGOD
ACHJO
ACHQT
ACJER
ACKOT
ACNCT
ACOFE
ACOXC
ACROE
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEBD
ADEYR
ADGDL
ADRRZ
ADUKH
ADULT
ADVBO
AECGH
AEEHM
AEGXH
AEGZQ
AELLO
AENEX
AEPTA
AEQLS
AESZF
AEUPB
AEWDL
AEWHI
AEXNY
AFAZI
AFEET
AFKRG
AFMOU
AFQAA
AFRAH
AFUIA
AGKLV
AGNAY
AGNHF
AGWFA
AHDMH
AHMBA
AIAGR
AJGYC
AJUXI
AJUZI
AJVBE
AJXAJ
AKBRZ
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
AOIJS
ARTOV
ASUFR
AS~
AUTPY
AYAKG
BAWUL
BBRGL
BCR
BDDNI
BES
BEYMZ
BKIIM
BKOMP
BLC
BPACV
BR6
CAG
CFDXU
CGR
COF
CS3
CUY
CVF
DC-
DC.
DIK
DOPDO
DU5
DV7
EBS
ECM
EIF
EIHBH
EJD
EX3
F5P
F8P
FAC
FAS
FHBDP
FJW
GIFXF
GOZPB
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GRPMH
GX1
H13
HVGLF
HYE
IHE
IPSME
J8X
JAA
JAAYA
JBMMH
JBZCM
JENOY
JHFFW
JKQEH
JLEZI
JLXEF
JPL
JST
K.F
KOO
L7B
LBL
LSO
LXL
LXN
LXY
M41
MVM
NHB
NPM
NQ-
O9-
OK1
OMK
OVD
P2P
PCD
PEA
PQQKQ
PRG
Q.-
Q2X
RIG
RNI
ROL
RPM
RPZ
RWL
RZO
SA0
SASJQ
SAUOL
SCNPE
SFC
SFH
SHG
SJN
SPV
TAE
TEORI
TN5
TR2
UHB
UKR
UNMZH
UXK
W2D
WH7
WOQ
WOW
X7M
XOL
XZL
Y4B
YOC
YR5
YRT
YSK
YYP
YZZ
Z0Y
ZGI
ZONMY
ZPPRI
ZRKOI
~KM
~X8
~ZZ
7X8
AJHME
ID FETCH-LOGICAL-c484t-90b4555e6300490ff1c2bfcc7060d4eb579e89f842f9a5eeccb7c9e8618e3afe2
IEDL.DBID 7X8
ISICitedReferencesCount 103
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000468808900009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1468-2877
IngestDate Sun Sep 28 09:03:49 EDT 2025
Mon Jul 21 06:02:49 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords flavors
tobacco
regulation
electronic cigarettes
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c484t-90b4555e6300490ff1c2bfcc7060d4eb579e89f842f9a5eeccb7c9e8618e3afe2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://journals.sagepub.com/doi/pdf/10.1177/0033354919830967
PMID 30857471
PQID 2190482422
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2190482422
pubmed_primary_30857471
PublicationCentury 2000
PublicationDate 2019-05-01
PublicationDateYYYYMMDD 2019-05-01
PublicationDate_xml – month: 05
  year: 2019
  text: 2019-05-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Public health reports (1974)
PublicationTitleAlternate Public Health Rep
PublicationYear 2019
SSID ssj0000213
Score 2.5561519
Snippet The use of flavored electronic cigarettes (e-cigarettes) is common among e-cigarette users, but little is known about the potential harms of flavorings, the...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 282
SubjectTerms Adolescent
Adult
Child
Electronic Nicotine Delivery Systems - statistics & numerical data
Female
Flavoring Agents
Humans
Male
Tobacco Products - statistics & numerical data
Vaping - epidemiology
Vaping - ethnology
Vaping - psychology
Young Adult
Title Use of Flavored E-Cigarettes Among Adolescents, Young Adults, and Older Adults: Findings From the Population Assessment for Tobacco and Health Study
URI https://www.ncbi.nlm.nih.gov/pubmed/30857471
https://www.proquest.com/docview/2190482422
Volume 134
WOSCitedRecordID wos000468808900009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qPQji-1FfjODRxX1ku1kvUsTFi7UHhd7KJplAQXdrty34P_zBTrJbexIELwsJZAnJZOabyWQ-xq64DuOQnC7PhDZ0IyPpCSSfx9e5DHzsoI61I5tIej0xGKT9JuBWNWmVC53oFLUulY2R39DJImEjgxLejT88yxplb1cbCo1V1ooIytiUrmSwrBZO9itavC4izyBZXlM6DrOIfCPyuSNC8cnvANMZmmz7v1PcYVsNxIRuLRO7bAWLPbZZx-egfna0z75eK4TSQPaWz8sJanjw7keO8pawJ3QtBRF0l9WersGpBeqavdlWXmh4tgTfTc8tZCP3PqaCbFK-A8FK6P9wg0H3p_4nEEiGF1IiSpXuL_WEwOYzfh6w1-zh5f7RaxgaPMUFn3qpL3kcx-jqdqW-MYEKpVHKluTRHGWcpChSI3ho0jxGEheZKOrqBAKj3GB4yNaKssBjBtQWGEg_ybnhsUmEygVtqeFSRYFG3WaXi0Uf0gmw1xp5geWsGi6Xvc2O6p0bjutSHcPIFvAn-3vyh9GnbIPQUFpnM56xlqHzj-dsXc2no2py4USLvr3-0zfDu9nR
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+Flavored+E-Cigarettes+Among+Adolescents%2C+Young+Adults%2C+and+Older+Adults%3A+Findings+From+the+Population+Assessment+for+Tobacco+and+Health+Study&rft.jtitle=Public+health+reports+%281974%29&rft.au=Soneji%2C+Samir+S&rft.au=Knutzen%2C+Kristin+E&rft.au=Villanti%2C+Andrea+C&rft.date=2019-05-01&rft.issn=1468-2877&rft.eissn=1468-2877&rft.volume=134&rft.issue=3&rft.spage=282&rft_id=info:doi/10.1177%2F0033354919830967&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1468-2877&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1468-2877&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1468-2877&client=summon